VYLR Vylor
A shrunken, loss-hit staples business still priced near 10x sales; realistic margin recovery doesn't justify the price.
The story
Vylor is a mid-sized consumer staples company that has just been heavily reshaped. Trailing revenue of $4.7B is less than half the last full-year figure of $10.07B, which points to a divestiture or spin, and the trailing operating margin of -41% and $1.67B net loss look like impairments and separation costs rather than how the business normally earns. What remains has staples-type brand strength and a net cash balance sheet. It is a mature, low-growth business, but its earnings will be noisy for a while as it absorbs the restructuring.
Target margin moves from 21% to 16% because the company has not come close to 21%: margins ran 10.1%, 11.7% and 6.7% over the last three years before the collapse, and 16% is a fair level for a staples business at scale. Margin years go from 3 to 5 because recovering from -41% will take longer, and year-1 growth drops to 3.5% (from 4.5%) to sit closer to the 3.1% five-year average on a smaller revenue base. Beta, sales-to-capital, terminal growth, failure probability and horizon are unchanged because none of the facts behind them moved.
Value drivers
| Revenue growth (Y1) | 3.5% |
| Terminal growth | 2.5% |
| Forecast horizon | 7y |
| Target operating margin | 16.0% |
| Years to target margin | 5 |
| Sales-to-capital | 1.20 |
| Beta | 0.70 |
| Failure probability | 2.0% |
| Cost of capital (WACC) | 7.4% |
| Terminal WACC | 8.8% |
Valuation bridge
| PV of explicit FCFF | -983.99M |
| PV of terminal value | 4.24B |
| Equity value | 3.89B |
| ÷ shares → per share | $5.83 |
Projected free cash flow to the firm
| Yr | Revenue | Growth | Margin | NOPAT | Reinvest | FCFF | PV |
|---|---|---|---|---|---|---|---|
| 1 | 4.86B | 3.5% | -29.5% | -930.66M | 136.94M | -1.07B | -993.65M |
| 2 | 5.02B | 3.3% | -18.1% | -590.70M | 134.98M | -725.69M | -628.65M |
| 3 | 5.18B | 3.2% | -6.7% | -226.69M | 132.51M | -359.20M | -289.61M |
| 4 | 5.34B | 3.0% | 4.6% | 160.71M | 129.51M | 31.20M | 23.42M |
| 5 | 5.49B | 2.8% | 16.0% | 570.64M | 125.98M | 444.66M | 310.58M |
| 6 | 5.63B | 2.7% | 16.0% | 585.85M | 121.93M | 463.92M | 301.59M |
| 7 | 5.77B | 2.5% | 16.0% | 600.50M | 117.36M | 483.14M | 292.33M |
Key risks
- The trailing revenue may not show the business's real earning power: if the halving is a partial-period effect rather than a divestiture, these drivers undervalue the company
- The remaining business may have weaker brands or less scale than the businesses that were sold, which would cap margins below 16%
- More impairments or stranded overhead from the separation could delay the margin recovery
Catalysts
- The first clean post-separation quarters, showing the underlying margin once one-time charges drop out
- Use of the $0.83B cash pile, and any buyback or bolt-on deal funded by the net cash position
⚠ Extreme gap to market price — large, heavily-covered stocks are rarely mispriced this much; the gap likely embeds disruption, decline, or balance-sheet risk the model underweights. Treat as a flag to investigate, not a verdict.